Diabetic microangiopathy

被引:15
作者
Dahl-Jorgensen, K [1 ]
机构
[1] Aker Univ Hosp, Dept Paediat, Aker Diabet Res Ctr, N-0514 Oslo, Norway
关键词
basement membrane thickening; biochemical changes; genetic influences; microangiopathy; microvascular complications;
D O I
10.1080/080352598750030582
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Microvascular complications of diabetes include retinopathy, nephropathy and neuropathy, The first signs of these complications may develop in children and adolescents, particularly if insulin treatment has been inadequate. The mechanisms by which diabetic microangiopathy develop are not known, but probably include genetic influences. Several biochemical changes may interact, one important change being increased protein glycation. Important functional changes are increased organ blood flow, increased vascular permeability, abnormal blood viscosity and abnormal platelet and endothelial function. The structural hallmark of diabetic microangiopathy is the thickening of the capillary basement membrane. These changes may lead to occlusive angiopathy and to tissue hypoxia and damage. Screening for microangiopathy should start in children and adolescents after 5-y duration of the disease and 10 y of age. The screening should include retinal examination through a dilated pupil or fundus photography, urinary albumin excretion rate, blood pressure measurement and neurological examination. Several intervention trials have shown that near normoglycaemia may reduce the risk of microangiopathy. There is a curvilinear association between the risk of development and progression of microangiopathy and mean blood glucose. Therefore, optimal insulin treatment is important in children and adolescents.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 33 条
  • [1] IMPROVEMENT OF BLOOD-GLUCOSE CONTROL IN IDDM PATIENTS RETARDS THE PROGRESSION OF MORPHOLOGICAL-CHANGES IN EARLY DIABETIC NEPHROPATHY
    BANGSTAD, HJ
    OSTERBY, R
    DAHLJORGENSEN, K
    BERG, KJ
    HARTMANN, A
    HANSSEN, KF
    [J]. DIABETOLOGIA, 1994, 37 (05) : 483 - 490
  • [2] BANGSTAD HJ, 1989, DIABETES RES CLIN EX, V12, P71
  • [3] Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus
    Berg, TJ
    Bangstad, HJ
    Torjesen, PA
    Osterby, R
    Bucala, R
    Hanssen, KF
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (06): : 661 - 665
  • [4] Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM
    Berg, TJ
    DahlJorgensen, K
    Torjesen, PA
    Hanssen, KF
    [J]. DIABETES CARE, 1997, 20 (06) : 1006 - 1008
  • [5] Bucala R, 1992, Adv Pharmacol, V23, P1
  • [6] RAPID TIGHTENING OF BLOOD-GLUCOSE CONTROL LEADS TO TRANSIENT DETERIORATION OF RETINOPATHY IN INSULIN DEPENDENT DIABETES-MELLITUS - THE OSLO STUDY
    DAHLJORGENSEN, K
    BRINCHMANNHANSEN, O
    HANSSEN, KF
    SANDVIK, L
    AAGENAES, O
    [J]. BRITISH MEDICAL JOURNAL, 1985, 290 (6471) : 811 - 815
  • [7] DAHLJORGENSEN K, 1987, ACTA ENDOCRINOL-COP, V115, P1
  • [8] BLOOD-GLUCOSE CONTROL AND MICROVASCULAR COMPLICATIONS - WHAT DO WE DO NOW
    DAHLJORGENSEN, K
    BRINCHMANNHANSEN, O
    BANGSTAD, HJ
    HANSSEN, KF
    [J]. DIABETOLOGIA, 1994, 37 (12) : 1172 - 1177
  • [9] DAHLJORGENSEN K, 1983, LANCET, V1, P652
  • [10] *DCCT RES GROUP, 1997, DIABETES, V46, P719